Mary C Guttieri

Author PubWeight™ 12.54^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Development of a new vaccine for the prevention of Lassa fever.	PLoS Med	2005	2.71
2	New opportunities for field research on the pathogenesis and treatment of Lassa fever.	Antiviral Res	2007	2.47
3	Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.	Antiviral Res	2005	1.38
4	Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.	Vaccine	2005	1.28
5	Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance.	Virol J	2008	1.10
6	Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment.	J Virol	2007	1.02
7	Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.	Antiviral Res	2011	0.94
8	Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.	Virol J	2008	0.93
9	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses.	PLoS Negl Trop Dis	2013	0.78